ArticlePloS one2026
Utility of three-dimensional echocardiography for evaluating right ventricular size and function and ventricular myocardial deformation in repaired tetralogy of fallot.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRight ventricular (RV) dysfunction remains a major long-term complication in patients with repaired Tetralogy of Fallot (rTOF). While cardiac magnetic resonance (CMR) is the gold standard for right ventricular (RV) assessment, it is limited by accessibility and cost. Three-dimensional echocardiography (3DE), with its strain imaging capabilities, offers a promising alternative for the serial evaluation of right ventricular (RV) size and function. This study aims to compare RV volumetric and myocardial deformation parameters obtained by 2D and 3D echocardiography (2DE, 3DE) with RV function measured by CMR in patients with rTOF. MATERIALS AND
methodsWe retrospectively analyzed 43 patients with rTOF who underwent same day 2D, 3D echocardiography, and CMR between November 2023 and December 2024. RV volumes, ejection fraction (RVEF), and global longitudinal strain (GLS) were measured across modalities. Correlation, Bland-Altman analysis, and area under receiver operating characteristic (AUC) curves were used to evaluate the agreement and diagnostic accuracy for detecting right ventricular (RV) systolic dysfunction.
resultsThree-DE demonstrated a strong correlation with CMR for RVEDV (r = 0.95) and RVEDVi (r = 0.91), with a mild underestimation. RVEF by 3DE was significantly lower than CMR (46.4 ± 8.8% vs. 50.3 ± 7.3%, p = 0.002). RV-GLS values differed across modalities, with 3DE yielding more negative values than 2DE (-20.3 ± 4.4% vs. -18.5 ± 4.7%, p = 0.009). Among patients with CMR-RVEF <48%, both 2D and 3D Echo-derived RV-GLS were significantly reduced.
conclusionThree-dimensional echocardiography demonstrates a consistent association with CMR for the assessment of right ventricular volumes but modest underestimation of volumetric and functional parameters. Abnormal right ventricular strain was observed in patients with CMR-defined systolic dysfunction, supporting the clinical relevance of strain analysis. Overall, 3DE may serve as a feasible complementary tool for longitudinal right ventricular assessment in patients with rTOF, alongside CMR as the reference standard.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.